Brexit
MHRA seeks comments on post-Brexit clinical trial legislation
Phil Taylor
Brexit, clinical trials, MHRA, regulatory
0 Comment
Market Access/ Views & Analysis/ Views and analysis
Post-Brexit medicines regulation must have international scope
Amanda Barrell
ABPI, Brexit, regulatory frameworks
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Deep Dive: Market Access
mike.hammerton@pharmaphorum.com
Boehringer Ingelheim, Brexit, Deep Dive, digital health, HTA, market access, NICE, patient centricity, patient engagement, sales
0 Comment
Market Access/ Views & Analysis/ Views and analysis
The Brexit deal; shot in the arm or kick in the teeth for the pharma sector?
UK chancellor Sunak urged to boost pharma and biotech in budget
Richard Staines
Biotech, Brexit, budget, investment, R&D, Rishi Sunak
0 Comment
News/ News/ Sales and Marketing
UK parliament backs EU trade deal, as industry sifts through detail
Phil Taylor
ABPI, BIA, Brexit, EFPIA, EU, trade, UK
0 Comment
NHS leaders urge UK government to extend Brexit transition period
Catherine Longworth
Brexit, COVID-19, European Union, NHS Confederation
0 Comment